Shanghai Pharma Of China Cleared To Raise $2 Billion With New IPO
This article was originally published in PharmAsia News
Executive Summary
China's Shanghai Pharmaceutical Holdings has been cleared to raise as much as $2 billion through an initial public offering on the Hong Kong stock exchange